The Journal of Obstetrics and Gynaecology of India
did-you-know
Clinical Pearls of JOGI SERIES OF WEBINARS Click her to view
VOL. 67 NUMBER 1 January-February  2017

Over-the-counter MTP Pills and Its Impact on Women’s Health

Sarojini1 • T. R. Ashakiran2 • B. T. Bhanu3 • Radhika4

Dr. Sarojini is an Assistant Professor in Department of OBG, BMCRI, Bangalore; Dr. T.R. Ashakiran is an Assistant Professor in Department of OBG, BMCRI, Bangalore; Dr. B.T. Bhanu is an ICMO in Department of OBG, BMCRI, Bangalore; Dr. Radhika is an Assistant Professor in Department of OBG, BMCRI, Bangalore.

Sarojini
prabhusaroj@gmail.com
1 Department of OBG, BMCRI, No. 55, 11th Main, Opposite Cluny Convent, Malleshwaram, Bangalore 560003, India
2 Department of OBG, BMCRI, No. 620, A4, Krishna Block, National Games Village, Koramangala, Bangalore 560047, India
3 Department of OBG, BMCRI, No. 20, Shravya, 40 Feet Road, 7th Cross, Manjunathanagar, Bangalore 560010, India
4 Department of OBG, BMCRI, No. 617, B4, Sharavathi Block, National Games Village, Koramangala, Bangalore 560047, India

  • Download Article
  • Email Article
  • Print Article
  • Whatsapp Article

About the Author


Dr. Sarojini graduated from Mysore Medical College and research institute and did postgraduation in OBST and GYN at the same institute. She is presently working as Assistant Professor in the department of OBG at Bangalore Medical College and Research Institute. She has presented a prize-winning paper at ISOPARB national conference in 2015. She has a keen interest in the area of publications as author as well as reviewer and has few publications in indexed journals.

Abstract

Objectives To study the complications and consequences including maternal morbidity and mortality following indiscriminate self-consumption of abortion pills reporting to a tertiary care center.

Methodology This is an observational study conducted at Vanivilas hospital between January 2012 to December 2013 for 24 months. After applying inclusion and exclusion criteria, 104 women were studied with respect to period of gestation, parity, clinical features at presentation and management in the institution. An analysis of maternal morbidity and mortality was done with respect to surgical interventions, ICU admissions, need for blood transfusions and maternal deaths.

Observations and results In this study, there were 75 (72.2 %) cases of incomplete abortion, 10 (9.6 %) cases of missed abortion, 2 (1.9 %) cases of ruptured ectopic and 2 (1.9 %) cases of rupture uterus. Seventy-eight (75 %) cases received blood transfusion, 7 (6.7 %) were admitted to ICU, and 2 (1.9 %) developed acute kidney injury. There were 2 (1.9 %) maternal deaths in the study group.

Conclusion This study shows urgent need for legislation and restriction of drugs used for medical termination of pregnancy. Drugs should be made available via health care facilities under supervision to reduce maternal mortality and morbidity due to indiscriminate use of these pills.

Keywords : Over the counter, MTP pills, Incomplete abortion, Rupture uterus, Blood transfusions

Introduction

Abortion is willful termination of the pregnancy before the period of viability. Excluding few instances, in most of the cases it is an outcome of unwanted pregnancy [1]. In India, abortion facility is available legally under MTP act, 1971. Despite this, women who want to terminate a pregnancy often ignore the legal status of abortions and have unsafe abortions. The WHO defines unsafe abortion as a procedure for terminating an unwanted pregnancy either by persons lacking the necessary skills or in an environment lacking minimal medical standards or both [2].

The World Health Organization (WHO) recommendations on medical abortion are restricted to early first trimester (up to 63 days since the first day of the last menstrual period) [3].

Antiprogesterone drugs such as mifepristone (RU 486) and prostaglandins like misoprostol have been approved by the United States Food and Drug Administration (USFDA) for medical abortion [4]. As per Medical Termination of Pregnancy (MTP) Act of India, this method can only be administered by gynecologists and registered medical practitioners (RMP) recognized for performing MTPs up to 49 days since the first day of LMP [5, 6]. The medical abortion carries a very high success rate of 93–98 % if they are used judiciously, that is, after properly assessing the gestational age as well as the health of the patient [7, 8]. Federation of Obstetrics and Gynecological Societies of India (FOGSI) recommends close monitoring of distribution of these drugs and that the medical profession and pharmaceutical industry should exercise due diligence in the promotion and usage of drugs that are used for medical abortion [9]. Despite this, it has been perceived by the society that medical abortions are extremely safe option even in the hands of untrained personnel, leading to overthe- counter dispensing and possible increase in unsupervised terminations and life-threatening complications [10]. Being a tertiary care center, we come across many cases of self-medication with abortion pills leading to many complications causing maternal mortality and morbidity.

Methodology

This is an observational study conducted at Vanivilas hospital between January 2012 to December 2013 for 24 months. This study is undertaken with the objective of studying the demographic features, various clinical features, complications, various management approaches carried out, maternal mortality and morbidity as a consequence of self-consumption of MTP pills.

All 104 women who reported to our hospital after selfconsumption of abortion pills (purchased over the counter by self/family member without medical guidance or supervision) are included in the study. Women who have consumed MTP pills after consulting a registered medical practitioner and reporting to us with complications and women who have undergone any surgical intervention after MTP pill consumption in other health care centers before reporting to our hospital are excluded from the study. History regarding previous pregnancies, gestational age at which MTP pills were taken, present complaints is noted. On admission, detailed general, systemic and obstetric examination and routine investigations were done in all women. Degree of pallor, rise in body temperature, sign’s of shock and presence of acute abdomen noted. Presence of retained products, incomplete abortion and ruptured ectopic pregnancy are documented after ultrasound examination. Management methods of all the complications, ICU admissions, need for blood and blood product transfusions and development of complications such as DIC, acute kidney injury and maternal death are noted. Following statistical methods were applied in the present study to evaluate the data.

1. Crosstabs procedure (contingency coefficient test)
2. Frequency distribution curve.

Results

A total of 104 cases were studied: The following data were obtained from the present study.

The age distribution of present study group is shown in Table 1. Sixty-six (63.4 %) women are within 30 years of age. Five (4.8 %) women in the study were unmarried. There were 9 (8.7 %) primis, 27 (26 %) second gravidas, 53 (51 %) third gravidas and 15 (14.3 %) women with obstetric score of gravida 4 and above in this study group. About 68 (65.4 %) women were gravida 3 or more, indicating that MTP tablet consumption might be to get rid of unwanted pregnancy.

Discussion

All women in this study easily procured the drug over thecounter at local pharmaceutical shops without priorcheckup at a healthcare facility. Drug administration wasnot supervised, and there was no adherence to the recom-mended schedule in most of the cases. Few women evendenied the procurement of the drug initially. As per theguidelines, medical termination of pregnancy should beoffered to women seeking termination of pregnancy up to7 weeks. These women should be of right frame of mindand must be prepared for at least 3 follow-up visits tohealth care facility.

In this study 4.8 % women are unmarried and 65.4 %women were gravida 3 or more; both data indicate thatMTP pill consumption might be to get rid of unwantedpregnancy.

Most common presentation on admission was bleedingper vagina (69.3 %) followed by pain abdomen. Similarresults are also reported by Thacker et al. [5] (89.1 %).35.6 % had consumed pills before 7 weeks of pregnancywhich is the recommended period for medical terminationof pregnancy. 64.4 % had taken the pills beyond the rec-ommended period of gestation, and 51 % had not followedthe recommended schedule or dosage of the regimen. This substantiates the findings by Thacker et al. [5] and Tran[11] that when there is a self-medication, women may takethe abortion pill whatever may be the gestational age andare not aware of possibility of serious life-threateningcondition like ectopic pregnancy, sepsis, hemorrhage anddeath.

On ultrasound examination, only 8.7 % had completeabortion rest and 91.3 % had incomplete abortion, missedabortion, continuation of pregnancy or rupture ectopic. All9 cases with complete abortion had taken the pills within7 weeks of gestational age and had come to us for slightbleeding per vagina.

There were 2 cases of rupture ectopic; both underwentlaparotomy and partial salpingectomy. Both patients hadneither undergone clinical examination nor ultrasoundevaluation before consuming the pill for medical abortion.This clearly suggests the need for clinical examination.Similar results about incidence of ectopic pregnancy arefound in the study conducted by Debnath et al. [12].

In this study, 75 % women were anemic requiring bloodand blood products transfusion. 52 % had received one-unittransfusion, whereas 23 % required transfusion of more thanone unit. In a study of 80,000 patients [13] over 18 months,only 0.01 % patients required blood transfusion when thedrugs were given under medical supervision. In a study byDeshpande et al. [14], no women required a blood transfu-sion when drugs are given under medical supervision.

Another complication that was found in our study wassepticemia. In present study, 3 women had septicemia. Outof them, 2 women responded to higher antibiotics andmaternal death occurred in 1 woman.

There were 2 cases of rupture uterus: One was 18-weekgestation with two prior cesarean deliveries with shock forwhich hysterectomy was done, and the second case was20-week gestation with one prior cesarean for which repairwas done.

ICU admissions accounted for 6.7 % of cases; amongthem, 4 were hemorrhagic shock and 3 had sepsis. Therewere 2 cases of acute kidney injury secondary to hemor-rhage requiring dialysis.

Among two maternal deaths, one was G3P2L2 with 2and half months of amenorrhea, had consumed MTP pills14 days prior and was bleeding for 10 days, reported to uswith incomplete abortion with irreversible hemorrhagicshock. The second case was a second gravida with2 months of amenorrhea, reported to us with septicemicshock, had consumed over-the-counter pills 18 days priorto reporting, was having bleeding per vagina for 15 daysand fever for 8 days. Both the women died within 12 h of admission.

Table5compares present study with studies of Thakeret al. [5] and Bajwa et al. [8]. All the three studies show comparable results.



Thirty-seven (35.6 %) cases had consumed pills before 7 weeks of pregnancy, 59 (56.7 %) had consumed between 7 and 12 weeks, and 8 (7.7 %) had consumed between 13 and 20 weeks. Seventy-three (70.2 %) cases had confirmed their pregnancy by getting a positive urine pregnancy test and 23(22.1 %) by a pelvic ultrasound examination before consuming the pills, whereas 8 (7.7 %) cases had neither of the tests done and had consumed the pills on the presumptive self-diagnosis of pregnancy. Fifty-three (51 %) had not followed the recommended schedule or dosage of the regimen. Excessive bleeding per vagina (69.3 %) is the most common presenting symptom followed by pain abdomen (11.5 %). Table 2 shows the clinical features at presentation to our hospital. All women except 2 cases were subjected to ultrasound examination after admission. Ultrasound findings are shown in Table 3. Two cases of rupture uterus were not subjected to ultrasound examination. Diagnosis is done by clinical examination followed by abdominal paracentesis. Complications developed at or after admission are listed down in Table 4. Seventy-eight (75 %) women were anemic requiring blood and blood products transfusion. Fiftyfour (52 %) had received one-unit transfusion, whereas 24 (23 %) required more than one-unit transfusion. In cases with incomplete abortion, missed abortion and blighted ovum instrumental evacuation was done. Those with rupture ectopic underwent laparotomy and partial salpingectomy. There were 7 (6.7 %) ICU admissions, 2 (1.9 %) cases of acute kidney injury and 2 (1.9 %) maternal deaths. Among two maternal deaths, one was due to hemorrhagic shock and the other one due to septicemic shock.

Compliance with Ethical Standards

Conflict of interest Dr. Sarojini, Dr. T.R. Ashakiran, Dr. B.T.Bhanu, and Dr. Radhika declare that we do not have any conflict ofinterest.

Ethical Approval All procedures followed were in accordance withthe ethical standards of the responsible committee on human exper-imentation (institutional and national) and with the Helsinki Decla-ration of 1975, as revised in 2008 (5). Ethical committee clearancefrom the institution was obtained.

Informed Consent Informed consent was obtained from all patientsfor being included in the study.

References

  1. Cunningham FG, Leveno KJ, Bloom SL, Haulh JC, Gilstrap LC,Wenstrom KD, editors. Abortion. Williams Textbook of Obstet-rics, 24th ed. New York: McGraw-Hill; 2014. pp. 215–235.
  2. Chaudhari SK. Pregnancy termination. In: Practice of FertilityControl a Comprehensive Manual, 7th ed. New Delhi: Elsevier;pp 237–263.
  3. International Consensus Conference on Non-surgical (Medical)Abortion in Early First Trimester on Issues Related to Regimensand Service Delivery. Frequently asked clinical questions aboutmedical abortion. Geneva: World Health Organization; 2006.ISBN 92-4-159484-5.
  4. Ellertson C, Waldman SN. The Mifepristone–Misoprostol regi-men for early medical abortion. Curr Women Health Rep.2001;1:184–90.
  5. Thaker RV, Deliwala KJ, Shah PT. Self medication of abortionpill: women’s Health in Jeopardy. NHL J Med Sci. 2014;3(1):26–31.
  6. http://www.mohfw.nic.in/index1.php?sublinkid=3613&level=3&lid=2597&lang=1.
  7. Kapur K, Joneja GS, Biswas M. Medical abortion—an alternativeto surgical abortion. MJAFI. 2006;62:351–3.
  8. Coyaji K. Early medical abortion in India: three studies and theirimplications for abortion services. J Am Med Womens Assoc.2000;55(3 suppl):191–4.
  9. http://www.fogsi.org/index.php?option=com_content&view=article&id=97&Itemid=16
  10. Bajwa SK, Bajwa SJS, Ghai GK, Singh N, Singh A, Goraya SPS.Medical abortion: is it a blessing or curse for the developingnations? Sri Lanka J Obstet Gynaecol. 2011;33(3):84–90.
  11. Tran NT, Jang MC, Choe YS, et al. Feasibility, efficacy, safetyand acceptability of Mifepristone–Misoprostol for medicalabortion in the Democratic People’s Republic of Korea. Int JGynecol Obstet. 2010;109(3):209–12.
  12. Debnath J, Gulati S, Mathur A, et al. Ectopic pregnancy in the eraof medical abortion: are we ready for it? Spectrum of sonographicfindings and our experience in a tertiary care service hospital ofIndia. J Obstet Gynecol India. 2013;66(6):388–93.
  13. Hausknecht R. Mifepristone and Misoprostol for early medicalabortion: 18 months experience in United States. Contraception.2003;67:463–5.
  14. Deshpande S, Yelikar K, Deshmukh A, et al. Comparative studyof medical abortion by Mifepristone with vaginal Misoprostol inwomen\49 days versus 50–63 days of amenorrhoea. J ObstetGynecol India. 2010;60(5):403–7
  • Download Aarticle
  • Email Aarticle
  • Print Article
  • Whatsapp Article